Search results

Opioid substitution treatment (OST), such as Buprenorphine, has become a well-established evidence-based approach for the treatment of inmates with opioid use disorder (OUD) in most of the developed world. However, its application in Lebanon remains mainly as a community-based intervention. The purpose of this paper is to highlight the need of its implementation within the Lebanese correctional system.

The work is a pilot cross-sectional study that compares two groups: 30 male adult prisoners with OUD convictions receiving symptomatic treatment and 30 male adult community patients with OUD receiving Buprenorphine. The objective was to measure the difference in the patients’ general perception and satisfaction of the treatments available. OUD was diagnosed using the Diagnostic and Statistical Manual of Mental Disorders 5th Edition criteria and the level of satisfaction was measured by “Treatment Perceptions Questionnaire (TPQ).”

The prison group reported significantly lower satisfaction when compared to the community group (total TPQ mean scores: M=34.73, SD =4.12 and M=16.67, SD =4.78, respectively, with t (56.76) =15.68, p=0.000). Furthermore, age, marital status, education level and elapsed time in treatment had no significant interactions with the total TPQ score.

The major principles of the ethics of care and evidence-based safe practices will be proposed for the introduction of Buprenorphine to Lebanese prisons. This work provides an opportunity for the expansion of the Lebanese OST program and consequently other countries in the region could benefit from this experience.

Elmar Mock's extraordinary story began in a small village in Switzerland. Born in 1954, he was the son of an Austrian immigrant and a Swiss mother. School was difficult, as he struggled with dyslexia. Nevertheless, he graduated from engineering school, obtained a job with a Swiss manufacturer, ETA. By the age of 26, he had co-invented the Swatch. Following the accidental death of his brother, Stéphane, in 1985, he decided to leave his job and launch his own creativity and innovation consulting company, Creaholic, in 1986.

In 2014, Elmar retired from Creaholic and created with his second wife Hélène Mock née Kett, a second company: ‘Mock-Kett’. He has created more than 80 families of patents in various industries and has been involved in more than 600 projects. He is also a member of the advisory boards of some of the spin-offs incubated by Creaholic. He remains active as a speaker and international consultant with ‘Mock-Kett’, which promotes the motivational side of invention. He has received numerous awards and his book ‘The Innovation Factory’ has been published in three languages.

The case depicts a one-of-a-kind creative mindset and offers in-depth reflections on the concepts of creativity, innovation and intrapreneurship and their applications in organizations. ¹